Clinical Trials

Evaluation of the Nucleus® Hybrid L24 Cochlear Implant System

Location:

Rochester,  MN

Trial status:

Open for Enrollment

Why is this study being done?

The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus® Hybrid L24 cochlear implant system.

Who is eligible to participate?

Participants eighteen years of age or older who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss.

What is involved?

If you agree to be in the study, you will be asked to complete a number of preoperative (before surgery) evaluations, and undergo cochlear implant surgery. Participants may require one or more medical appointments during their recovery from surgery and will attend up to 6 postoperative (after surgery) study-related appointments over a 1-year period and then semi-annually until the Sponsor closes the study.

How long is the study?

Participants will be enrolled in this study for approximately 2 to 3 years, though the majority of the postoperative evaluations will take place in the initial 12 months following surgery.

Last updated: 12/05/2012

NCT ID: